tetradecanoylphorbol acetate and Generalized Resistance to Thyroid Hormone

tetradecanoylphorbol acetate has been researched along with Generalized Resistance to Thyroid Hormone in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fiering, SN; Galton, VA; Pallud, SE; Parlow, AF; Schneider, MJ; St Germain, DL	1

Other Studies

1 other study(ies) available for tetradecanoylphorbol acetate and Generalized Resistance to Thyroid Hormone

Article	Year
Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4. Molecular endocrinology (Baltimore, Md.), 2001, Volume: 15, Issue:12 Topics: Adipose Tissue, Brown; Animals; Astrocytes; Blotting, Northern; Colforsin; Female; Hypothyroidism; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pituitary Gland; Tetradecanoylphorbol Acetate; Thyroid Hormone Resistance Syndrome; Thyrotropin; Thyroxine; Triiodothyronine	2001

Article

Year

Targeted disruption of the type 2 selenodeiodinase gene (DIO2) results in a phenotype of pituitary resistance to T4.

Molecular endocrinology (Baltimore, Md.), 2001, Volume: 15, Issue:12

Topics: Adipose Tissue, Brown; Animals; Astrocytes; Blotting, Northern; Colforsin; Female; Hypothyroidism; Iodide Peroxidase; Iodothyronine Deiodinase Type II; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Pituitary Gland; Tetradecanoylphorbol Acetate; Thyroid Hormone Resistance Syndrome; Thyrotropin; Thyroxine; Triiodothyronine

2001